O

OrbusNeich Medical Group Holdings Ltd
HKEX:6929

Watchlist Manager
OrbusNeich Medical Group Holdings Ltd
HKEX:6929
Watchlist
Price: 4.1 HKD -1.68% Market Closed
Market Cap: 3.4B HKD
Have any thoughts about
OrbusNeich Medical Group Holdings Ltd?
Write Note

OrbusNeich Medical Group Holdings Ltd
Operating Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

OrbusNeich Medical Group Holdings Ltd
Operating Income Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Operating Income CAGR 3Y CAGR 5Y CAGR 10Y
O
OrbusNeich Medical Group Holdings Ltd
HKEX:6929
Operating Income
$39.4m
CAGR 3-Years
79%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
H
Huakang Biomedical Holdings Co Ltd
HKEX:8622
Operating Income
-ÂĄ6.4m
CAGR 3-Years
7%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
K
Kaisa Health Group Holdings Ltd
HKEX:876
Operating Income
-HK$52.1m
CAGR 3-Years
-6%
CAGR 5-Years
-22%
CAGR 10-Years
-6%
K
Kelfred Holdings Ltd
HKEX:1134
Operating Income
-HK$13m
CAGR 3-Years
-46%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Arts Optical International Holdings Ltd
HKEX:1120
Operating Income
HK$35.8m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
0%
No Stocks Found

OrbusNeich Medical Group Holdings Ltd
Glance View

Market Cap
3.4B HKD
Industry
Health Care

OrbusNeich Medical Group Holdings Ltd. operates as an investment holding company. The company employs 880 full-time employees The company went IPO on 2022-12-23. The firm is engaged in the design, development, manufacture, distribution and sale of interventional medical devices for the treatment of coronary heart disease and peripheral vascular diseases. The firm's main products include percutaneous coronary intervention (PCI) and percutaneous transluminal angioplasty (PTA) balloons. In addition, the Company's products also include semi-compliant balloons and scoring balloons for pre-dilatation and lesion preparation, coronary stents for implantation, non-compliant balloons for post-dilatation and specialty catheters. The firm mainly conducts its businesses in domestic and overseas markets.

Intrinsic Value
4.36 HKD
Undervaluation 6%
Intrinsic Value
Price
O

See Also

What is OrbusNeich Medical Group Holdings Ltd's Operating Income?
Operating Income
39.4m USD

Based on the financial report for Dec 31, 2023, OrbusNeich Medical Group Holdings Ltd's Operating Income amounts to 39.4m USD.

What is OrbusNeich Medical Group Holdings Ltd's Operating Income growth rate?
Operating Income CAGR 3Y
79%

Over the last year, the Operating Income growth was 65%. The average annual Operating Income growth rates for OrbusNeich Medical Group Holdings Ltd have been 79% over the past three years .

Back to Top